Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN251007 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Chromatin Licensing and DNA Replication Factor 1 (CDT1) (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term
- Vial size
- 100 μL
- Storage
- Store at 4°C. Do not freeze.
- Handling
- Do not freeze.
Submitted references A nontranscriptional role for HIF-1α as a direct inhibitor of DNA replication.
MCM proteins are negative regulators of hypoxia-inducible factor 1.
The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing.
Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma.
Hubbi ME, Kshitiz, Gilkes DM, Rey S, Wong CC, Luo W, Kim DH, Dang CV, Levchenko A, Semenza GL
Science signaling 2013 Feb 12;6(262):ra10
Science signaling 2013 Feb 12;6(262):ra10
MCM proteins are negative regulators of hypoxia-inducible factor 1.
Hubbi ME, Luo W, Baek JH, Semenza GL
Molecular cell 2011 Jun 10;42(5):700-12
Molecular cell 2011 Jun 10;42(5):700-12
The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing.
Kim Y, Starostina NG, Kipreos ET
Genes & development 2008 Sep 15;22(18):2507-19
Genes & development 2008 Sep 15;22(18):2507-19
Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma.
Pos Z, Wiener Z, Pocza P, Racz M, Toth S, Darvas Z, Molnar V, Hegyesi H, Falus A
Cancer research 2008 Mar 15;68(6):1997-2005
Cancer research 2008 Mar 15;68(6):1997-2005
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC